Investigating the Neurobiology of Tinnitus

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT01294124
Collaborator
United States Department of Defense (U.S. Fed)
218
1
37.6
5.8

Study Details

Study Description

Brief Summary

The investigators hypothesize that individual differences exist in resting-state cortical attention, control, sensory, and emotion networks prior to noise exposure and these differences predispose some to the development of bothersome tinnitus. Furthermore, the investigators hypothesize that these changes in functional connectivity of these vulnerable systems after noise exposure are responsible for tinnitus. The proposed study will use a case-control cohort study design. Cases will be those soldiers who develop tinnitus and controls will be those who do not. This will be the first prospective study of tinnitus and will provide important information about the neurobiology of tinnitus.

If a cortical neural network etiology for bothersome tinnitus is confirmed, it will be an astounding, powerful, paradigm shifting model for the diagnosis, prevention and, most importantly, treatment of tinnitus. Furthermore, if a battery of neurocognitive tests can identify soldiers at risk for the development of tinnitus then appropriate primary prevention strategies can be introduced.

There are three Specific Aims to this project.

Specific Aim 1. To determine if soldiers who develop tinnitus display pre-deployment differences in a set of physical, functional, cognitive, vulnerability, perpetuating factors, pre-deployment neurocognitive scores, or neuroimaging features compared to soldiers who do not develop tinnitus ("control group").

Specific Aim 2. To determine if particular scores on neurocognitive tests or neuroimaging features of functional/structural connectivity networks are associated with the development of tinnitus.

Specific Aim 3. To identify a set of pre-deployment physical, functional, cognitive, vulnerability, and perpetuating factors, neurocognitive responses, and neuroimaging features that are associated with the development of tinnitus.

The investigators plan to recruit 200 soldiers, between the ages of 18 and 30 years who do not have hearing loss or tinnitus and have never been deployed to military theater. The soldier participants will undergo a variety of tests before and after deployment, which will include a hearing test, neurocognitive tests (i.e., brain function tests), and a variety of novel radiologic imaging studies of the brain. One of these novel radiologic imaging studies is functional connectivity Magnetic Resonance Imaging, a proven methodology that monitors changes in brain activity and connections based on blood flow between different brain areas and levels of consumption of oxygen. This information is used to describe the condition of important neural networks responsible for such things as attention, mood, sensation, vision, hearing, and introspection or self-contemplation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    218 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Investigating The Neurobiology of Tinnitus
    Actual Study Start Date :
    May 25, 2016
    Actual Primary Completion Date :
    Jul 12, 2019
    Actual Study Completion Date :
    Jul 12, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    No Tinnitus

    The absence of tinnitus will be based on the participants' responses to questions 8a, 9c, and 9d of the Post-Deployment Health Assessment (PDHA).

    Tinnitus

    The presence of tinnitus will be based on the participants' responses to questions 8a, 9c, and 9d of the Post-Deployment Health Assessment (PDHA).

    Outcome Measures

    Primary Outcome Measures

    1. Development of Tinnitus [Post-deployment assessment will occur no sooner than 90 days from return from active military theater.]

      The presence of tinnitus will be based on the participants' responses to questions 8a, 9c, and 9d of the Post-Deployment Health Assessment (PDHA).

    Secondary Outcome Measures

    1. Mild Traumatic Brain Injury [Post-deployment assessment will occur no sooner than 90 days from return from active military theater.]

      Mild Traumatic Brain Injury - Ohio State University TBI Identification Method (OSU TBI-ID version 12-10-08)(Corrigan and Bogner 2007)

    2. Post Traumatic Stress Disorder [Post-deployment assessment will occur no sooner than 90 days from return from active military theater.]

      Subjects whose military medical record or PDHA suggests PTSD will be asked to complete the Clinician Administered PTSD Scale (CAPS).(Blake et al. 1995; Weathers and Litz 1994)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 30 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Active duty or reserve military personnel with MOS job code 11B, 11C, 19D, or 19K

    • Men and women between the ages of 18 and 30 years

    • Scheduled for first deployment to military theater

    • Must be able to read, write, and understand English

    • Willing to sign Request Pertaining to Military Records (Form 180) to allow study personnel to access medical records for the purposes of this study.

    Exclusion Criteria:
    • History of hearing loss or tinnitus

    • Currently taking medication for depression, anxiety, or other DSM IV Axis 1 disorder

    • History of head trauma sufficient to cause loss of consciousness for 30 minutes or greater

    • History of surgery to the brain

    • History of claustrophobia

    • Presence of metallic implants in the head and upper cervical region that are non-MRI compatible and would prohibit use of MRI.

    • At any time in the past, prior deployment or employment in military theater

    • Currently pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Naval Medical Center San Diego California United States 92134

    Sponsors and Collaborators

    • Washington University School of Medicine
    • United States Department of Defense

    Investigators

    • Principal Investigator: Jay F. Piccirillo, MD, Washington University School of Medicine
    • Principal Investigator: Sean Wise, CAPT., M.D., United States Naval Medical Center, San Diego

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Washington University School of Medicine
    ClinicalTrials.gov Identifier:
    NCT01294124
    Other Study ID Numbers:
    • NMCSD.2013.0021
    • CDMRP
    First Posted:
    Feb 11, 2011
    Last Update Posted:
    Dec 16, 2019
    Last Verified:
    Dec 1, 2019

    Study Results

    No Results Posted as of Dec 16, 2019